Lilian Gien, MD, Reviews Pembrolizumab Plus Epacadostat in Recurrent Clear Cell Carcinoma of the Ovary

During the 2022 Global Annual Meeting of the International Gynecologic Cancer SocietyCancerNetwork® spoke to Lilian Gien,…

Pembrolizumab in Combination with Lenvatinib as First-Line Treatment for Non Clear Cell Renal Cell Carcinoma (nccRCC), KEYNOTE-B61

Read the full video transcript Pedro Barata: Hello and welcome. My name is Pedro Barata. I…